Ertis Hydrometallurgical Plant appoints new general director

Vitaly Nesis Chief Executive Officer Polymetal International
Vitaly Nesis Chief Executive Officer - Polymetal International
0Comments

Vladimir Dudin has been appointed as the new general director of Ertis Hydrometallurgical Plant LLP. With over 26 years of experience in construction, energy, management, and administration, Dudin brings expertise in large-scale projects, including autoclave oxidation technology.

Dudin is a graduate of Kaliningrad State Technical University. Before this appointment, he led the Amursk branch of Polymetal Managing Company JSC, overseeing the development of the second phase of the Amursk Hydrometallurgical Plant (Amursk POX). From 2014 to 2017, he managed the logistics division at Bakyrchik mining enterprise under Solidcore Resources.

“We welcome Vladimir Dudin to Solidcore Resources. The team led by Vladimir Dudin worked hard and well-coordinated to ensure the successful launch of the second stage of Amursk POX. His experience will be invaluable to the development and launch of Ertis POX,” stated Vitaly Nesis, CEO of Solidcore Resources.

Arman Beisembinov, who previously held the position at Ertis Hydrometallurgical Plant LLP, has been named Deputy General Director responsible for interactions with government agencies and the public.

Ertis POX is an investment project by Solidcore Resources and is one of 17 major projects within Kazakhstan’s metallurgical and petrochemical sectors. The plant aims to process high-carbon sulfide gold-containing concentrates locally, enabling a complete cycle of refined gold production in Kazakhstan using autoclave oxidation technology.

Solidcore Resources’ portfolio includes two operating gold mines and a promising growth project. The company employs over 3,000 people.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.